A Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Rectal Cancer
Clinical trial NCT07223567 · WITHDRAWN
Trial details
- NCT number
- NCT07223567
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-27
- Primary completion
- 2026-01-22
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.